Kazakhstan vs Lithuania: New cases tested for RR-/MDR-TB
Kazakhstan
100.0%
in 2024
Lithuania
100.0%
in 2024
Kazakhstan rank
1st
Lithuania rank
1st
New cases tested for RR-/MDR-TB over time
- Kazakhstan
- Lithuania
How they compare
Kazakhstan currently reports 100.0% against 100.0% in Lithuania, a difference of 0.0%.
Across all 19 years both countries report, Lithuania has been ahead every year.
Kazakhstan ranks 1st and Lithuania ranks 1st of 192 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.0% | 100.0% | 27.0% | Lithuania |
| 2010s | 97.1% | 100.0% | 2.9% | Lithuania |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Kazakhstan or Lithuania?
- Kazakhstan, at 100.0% against 100.0% in Lithuania as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Kazakhstan and Lithuania?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Lithuania?
- 19 years are reported by both, from 2006 to 2024.
- How do Kazakhstan and Lithuania rank globally for new cases tested for rr-/mdr-tb?
- Kazakhstan ranks 1st and Lithuania ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.